How Bendheim was paid
$5.2M in total for 2026, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Incentive | Pension | Other | Total |
|---|---|---|---|---|---|---|---|
| Jack C. BendheimChairman of the Board and Executive Chairman | $2,442,600 | — | $424,255 | $1,587,690 | $117,108 | $658,245 | $5,229,898 |
| Daniel M. BendheimPresident and Chief Executive Officer | $575,000 | — | $99,866 | $373,750 | $15,663 | $55,815 | $1,120,094 |
| Glenn DavidChief Financial Officer | $702,768 | — | $122,060 | $456,800 | — | $52,094 | $1,333,722 |
| Larry L. MillerChief Operating Officer | $751,849 | $1,062,500 | $130,602 | $488,701 | $12,844 | $54,123 | $2,500,619 |
| Judith WeinsteinSenior Vice President, General Counsel and Corporate Secretary | $500,000 | — | $86,841 | $325,000 | $7,988 | $55,357 | $975,186 |
What changed and why
- $71,10074:1 was the CEO-to-median-employee pay ratio, with median annual compensation of $71,100.
- $5.2MCEO total compensation fell to $5,229,898 from $5,284,122 in 2025, while salary stayed at $2,442,600.
- 18%18% of base salary was delivered through three-year RSU grants in lieu of merit-based salary increases.
- $1.2MCEO MIP target compensation was $1,221,300, while actual non-equity incentive compensation was $1,587,690.
- $550K$550,000 was the maximum fiscal 2026 cost of Jack Bendheim’s family legal, accounting and tax planning services.
- July 1, 2026 marked Daniel Bendheim’s CEO transition and Jack Bendheim’s move to Executive Chairman.
Other Phibro Animal Health proxy statements
- 2025 proxy statement
Jack C. Bendheim paid $5.3M (+11% on the year), pay ratio 95:1.
Filed Sep 19, 2025
About this page
The figures were read out of the DEF 14A proxy statement on EDGAR by a language model and every number was then checked against the filing text; a figure that could not be found there is left out rather than shown. Totals follow SEC rules, which value stock and option awards at grant. Read the filing for footnotes and the compensation committee's full reasoning.